DISCLOSURE UNDER REGULATION 29(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011 RECEIVED FROM MR. SUDHIR SETHI, PROMOTER OF THE COMPANY
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Sudhir Sethi, a promoter of Beryl Drugs Ltd, acquired 3,040 equity shares on 13-03-2026 through market transactions, representing 0.06% of the company's paid-up capital. His total holding increased from 4,70,143 shares (9.27%) to 4,73,183 shares (9.33%) after the purchase. The total equity share capital of the company remains 50,71,700 shares. The disclosure was filed under Regulation 29(2) of SEBI's Takeover Regulations, with the company's managing director submitting the intimation to BSE on 14-03-2026. Part B of the filing also identifies other promoters including Sanjay Sethi, Sangita Sethi, and Soniya Sethi as persons acting in concert.
The acquisition is small (0.06%) and is unlikely to materially affect the stock price, though it signals continued promoter confidence. Sudhir Sethi remains a non-controlling promoter with under 10% stake, and the purchase is a routine incremental buy rather than a meaningful change in ownership structure.